StockData
Bausch & Lomb Corp logo

Bausch & Lomb Corp (BLCO) stock

BLCONYSEOphthalmic GoodsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 9/3026% below fair value
$21.09−0.05 (-0.24%)

Close on Nov 13, 2026Market cap $7.54BP/E –Yield –

Earnings

Bausch & Lomb's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 17, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$1.38B
+7.3% on a year earlier
Adjusted EPS attributable to Bausch + Lomb Corporation (non-GAAP), Q3 FY2026
$0.34
$0.18 a year earlier
Latest guidance
Issued
Oct 28, 2026 · 3 items

Quarterly results

Revenue and earnings per share from each of Bausch & Lomb's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Feb 17, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Oct 28, 2026before the open$1.38B+7.3%$0.09$0.34Release
Q2 FY2026ended Jun 30, 2026Jul 29, 2026before the open$1.39B+9.1%-$0.04$0.15Release
Q1 FY2026ended Mar 31, 2026Apr 29, 2026before the open$1.24B+9.4%-$0.20$0.05Release
Q4 FY2025ended Dec 31, 2025Feb 18, 2026before the open$1.41B+9.8%-$0.16$0.32Release
Q3 FY2025ended Sep 30, 2025Oct 29, 2025before the open$1.28B+7.1%-$0.08$0.18Release
Q2 FY2025ended Jun 30, 2025Jul 30, 2025before the open$1.28B+5.1%-$0.18$0.07Release
Q1 FY2025ended Mar 31, 2025Apr 30, 2025before the open$1.14B+3.5%-$0.60-$0.15Release
Q4 FY2024ended Dec 31, 2024Feb 19, 2025before the open$1.28B+9.1%-$0.01$0.25Release
Q3 FY2024ended Sep 30, 2024Oct 30, 2024before the open$1.20B+18.8%$0.01$0.13Release
Q2 FY2024ended Jun 30, 2024Jul 31, 2024before the open$1.22B+17.5%-$0.43$0.13Release
Q1 FY2024ended Mar 31, 2024May 1, 2024before the open$1.10B+18.0%-$0.48$0.07Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Bausch & Lomb's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
constant currency growthnon-GAAPFY2026+6.1% – +8%–NewOct 28, 2026
constant currency growthnon-GAAPFY2026+5.8% – +7.7%+5.3% – +7.2%RaisedJul 29, 2026
Full-Year RevenueGAAPFY2026$5.45B – $5.55B–NewOct 28, 2026
Full-Year RevenueGAAPFY2026$5.44B – $5.54B$5.38B – $5.48BRaisedJul 29, 2026
Full-Year RevenueFY2026$5.42B – $5.52B–NewApr 29, 2026
Full-Year Adjusted EBITDA Excluding Acquired IPR&D (non-GAAP)non-GAAPFY2026$1.09B – $1.14B–NewOct 28, 2026
Full-Year Adjusted EBITDA Excluding Acquired IPR&D (non-GAAP)non-GAAPFY2026$1.03B – $1.08B$1.01B – $1.06BRaisedJul 29, 2026

Guidance vs results

The last range Bausch & Lomb gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2025Revenue$5.05B – $5.15B$5.10BΣ4QWithin range

Guidance history

Every forecast Bausch & Lomb put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Oct 28, 2026Full-Year Adjusted EBITDA Excluding Acquired IPR&D (non-GAAP)FY2026$1.09B – $1.14BNew
Oct 28, 2026constant currency growthFY2026+6.1% – +8%New
Oct 28, 2026Full-Year RevenueFY2026$5.45B – $5.55BNew
Jul 29, 2026Full-Year Adjusted EBITDA Excluding Acquired IPR&D (non-GAAP)FY2026$1.03B – $1.08BRaised
Jul 29, 2026constant currency growthFY2026+5.8% – +7.7%Raised
Jul 29, 2026Full-Year RevenueFY2026$5.44B – $5.54BRaised
Apr 29, 2026Full-Year Adjusted EBITDA Excluding Acquired IPR&D (non-GAAP)FY2026$1.01B – $1.06BRaised
Apr 29, 2026Full-Year RevenueFY2026$5.42B – $5.52BNew
Apr 29, 2026constant currency growthFY2026+5.3% – +7.2%Raised
Feb 18, 2026Full-Year Adjusted EBITDA Excluding Acquired IPR&D (non-GAAP)FY2026$1.00B – $1.05BNew
Feb 18, 2026constant currency growthFY2026+5% – +7%New
Feb 18, 2026Full-Year RevenueFY2026$5.38B – $5.48BNew
Oct 29, 2025Full-Year Adjusted EBITDA Excluding Acquired IPR&D (non-GAAP)FY2025$870.00M – $910.00MNew
Oct 29, 2025Full-Year Revenue constant currency growthFY2025+5% – +7%New
Oct 29, 2025Full-Year RevenueFY2025$5.05B – $5.15BNew
Jul 30, 2025Full-Year Adjusted EBITDA Excluding Acquired IPR&D (non-GAAP)FY2025$860.00M – $910.00MRaised
Jul 30, 2025Full-Year RevenueFY2025$5.05B – $5.15BRaised
Jul 30, 2025constant currency growthFY2025+5% – +7%Raised
Apr 30, 2025Full-Year Adjusted EBITDA Excluding Acquired IPR&D (non-GAAP)FY2025$850.00M – $900.00MLowered
Apr 30, 2025Full-Year One-Time Impact of enVista Recall on RevenueFY2025-$55.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Bausch & Lomb filed with the SEC as exhibits to Form 8-K or 6-K

  1. Bausch + Lomb Posts Strong Third-Quarter Performance, Raises Full-Year 2026 Guidance
    Results
  2. Bausch + Lomb and Bausch Health Announce Appointment
    Update
  3. Bausch + Lomb Announces Board of Directors Update,
    News
  4. Bausch + Lomb Delivers Broad-Based Second-Quarter Growth, Raises Full-Year 2026 Guidance
    Results
  5. Bausch + Lomb Announces First-Quarter 2026 Results, Raises Guidance Based on Strong Performance and Positive Outlook
    Results
  6. Bausch + Lomb Announces Fourth-Quarter and Full-Year 2025 Results,
    Results
  7. Bausch + Lomb Completes Refinancing of Outstanding
    News
  8. Bausch + Lomb Announces Refinancing of Outstanding
    News
  9. Bausch + Lomb to Highlight Company Transformation
    Update
  10. ​ INVESTOR DAY ​ November 13 th , 2025
    Update
  11. Bausch + Lomb Announces Third-Quarter 2025 Results
    Results
  12. Bausch + Lomb Announces Board Changes
    Update
  13. Bausch + Lomb Announces Second-Quarter 2025 Results
    Results
  14. Bausch + Lomb Announces Closing of Upsized €675 Million Senior Secured Notes Offering and Partial
    News
  15. Announces Pricing of Upsized Senior Secured Notes Offering
    News

See a number that looks wrong?